Obesity may contribute to Japanese COVID-19 death rate

Abstract

OECD countries will spend about 8.4% of their health budget to provide treatment for overweight-related diseases. On average in OECD countries, overweight will be responsible for 70% of all treatment costs for diabetes, 23% of treatment costs for cardiovascular diseases and 9% for cancers. Overweight and its related conditions will reduce gross domestic product (GDP) by 3.3% in OECD countries through increasing workplace absenteeism and lowering productivity.